Literature DB >> 21172883

Bilateral adrenal medullary hyperplasia associated with an SDHB mutation.

Raymon H Grogan1, Karel Pacak, Lezlee Pasche, Thanh T Huynh, Ralph S Greco.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21172883     DOI: 10.1200/JCO.2010.32.2156

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  17 in total

1.  Pathological and Genetic Characterization of Bilateral Adrenomedullary Hyperplasia in a Patient with Germline MAX Mutation.

Authors:  Pauline Romanet; Carole Guerin; Pascal Pedini; Wassim Essamet; Frédéric Castinetti; Fréderic Sebag; Philippe Roche; Alberto Cascon; Arthur S Tischler; Karel Pacak; Anne Barlier; David Taïeb
Journal:  Endocr Pathol       Date:  2017-12       Impact factor: 3.943

2.  Pituitary adenoma with paraganglioma/pheochromocytoma (3PAs) and succinate dehydrogenase defects in humans and mice.

Authors:  Paraskevi Xekouki; Eva Szarek; Petra Bullova; Alessio Giubellino; Martha Quezado; Spyridon A Mastroyannis; Panagiotis Mastorakos; Christopher A Wassif; Margarita Raygada; Nadia Rentia; Louis Dye; Antony Cougnoux; Deloris Koziol; Maria de La Luz Sierra; Charalampos Lyssikatos; Elena Belyavskaya; Carl Malchoff; Jessica Moline; Charis Eng; Louis James Maher; Karel Pacak; Maya Lodish; Constantine A Stratakis
Journal:  J Clin Endocrinol Metab       Date:  2015-02-19       Impact factor: 5.958

3.  Implications of SDHB genetic testing in patients with sporadic pheochromocytoma.

Authors:  Aurelie Maignan; Carole Guerin; Valentin Julliard; Nunzia-Cinzia Paladino; Edward Kim; Philippe Roche; Fréderic Castinetti; Wassim Essamet; Julien Mancini; Alessio Imperiale; Roderick Clifton-Bligh; Pauline Romanet; Anne Barlier; Karel Pacak; Fréderic Sebag; David Taïeb
Journal:  Langenbecks Arch Surg       Date:  2017-02-22       Impact factor: 3.445

4.  Succinate dehydrogenase (SDH) D subunit (SDHD) inactivation in a growth-hormone-producing pituitary tumor: a new association for SDH?

Authors:  Paraskevi Xekouki; Karel Pacak; Madson Almeida; Christopher A Wassif; Pierre Rustin; Maria Nesterova; Maria de la Luz Sierra; Joey Matro; Evan Ball; Monalisa Azevedo; Anelia Horvath; Charalampos Lyssikatos; Martha Quezado; Nicholas Patronas; Barbara Ferrando; Barbara Pasini; Aristides Lytras; George Tolis; Constantine A Stratakis
Journal:  J Clin Endocrinol Metab       Date:  2011-12-14       Impact factor: 5.958

Review 5.  Overview of the 2022 WHO Classification of Familial Endocrine Tumor Syndromes.

Authors:  Vania Nosé; Anthony Gill; José Manuel Cameselle Teijeiro; Aurel Perren; Lori Erickson
Journal:  Endocr Pathol       Date:  2022-03-13       Impact factor: 3.943

Review 6.  The 3PAs: An Update on the Association of Pheochromocytomas, Paragangliomas, and Pituitary Tumors.

Authors:  Paraskevi Xekouki; Ana Brennand; Ben Whitelaw; Karel Pacak; Constantine A Stratakis
Journal:  Horm Metab Res       Date:  2018-10-01       Impact factor: 2.936

Review 7.  Hyperplasia in glands with hormone excess.

Authors:  Stephen J Marx
Journal:  Endocr Relat Cancer       Date:  2015-09-25       Impact factor: 5.678

8.  Protocol for the examination of specimens from patients with pheochromocytomas and extra-adrenal paragangliomas.

Authors:  Ozgur Mete; Arthur S Tischler; Ronald de Krijger; Anne Marie McNicol; Graeme Eisenhofer; Karel Pacak; Shereen Ezzat; Sylvia L Asa
Journal:  Arch Pathol Lab Med       Date:  2014-02       Impact factor: 5.534

Review 9.  Carney Triad, Carney-Stratakis Syndrome, 3PAS and Other Tumors Due to SDH Deficiency.

Authors:  Georgia Pitsava; Nikolaos Settas; Fabio R Faucz; Constantine A Stratakis
Journal:  Front Endocrinol (Lausanne)       Date:  2021-05-03       Impact factor: 5.555

Review 10.  Toward an improved definition of the genetic and tumor spectrum associated with SDH germ-line mutations.

Authors:  Lucie Evenepoel; Thomas G Papathomas; Niels Krol; Esther Korpershoek; Ronald R de Krijger; Alexandre Persu; Winand N M Dinjens
Journal:  Genet Med       Date:  2014-11-13       Impact factor: 8.822

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.